ImmunoPrecise Antibodies Ltd (IPA)
0.392
+0.02
(+4.26%)
USD |
NASDAQ |
Nov 25, 16:00
0.392
0.00 (0.00%)
After-Hours: 20:00
ImmunoPrecise Antibodies Revenue (TTM): 17.73M for July 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
July 31, 2024 | 17.73M |
April 30, 2024 | 18.15M |
January 31, 2024 | 17.54M |
October 31, 2023 | 16.77M |
July 31, 2023 | 16.13M |
April 30, 2023 | 15.51M |
January 31, 2023 | 15.50M |
October 31, 2022 | 15.47M |
July 31, 2022 | 15.33M |
April 30, 2022 | 15.42M |
January 31, 2022 | 15.16M |
October 31, 2021 | 14.87M |
July 31, 2021 | 14.71M |
April 30, 2021 | 13.73M |
January 31, 2021 | 12.87M |
October 31, 2020 | 12.43M |
July 31, 2020 | 11.22M |
April 30, 2020 | 10.52M |
January 31, 2020 | 9.482M |
October 31, 2019 | 8.440M |
July 31, 2019 | 8.135M |
April 30, 2019 | 8.292M |
January 31, 2019 | 7.731M |
October 31, 2018 | 7.070M |
July 31, 2018 | 6.039M |
Date | Value |
---|---|
April 30, 2018 | 4.284M |
January 31, 2018 | 3.309M |
October 31, 2017 | 2.329M |
July 31, 2017 | |
April 30, 2017 | |
January 31, 2017 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
9.482M
Minimum
Jan 2020
18.15M
Maximum
Apr 2024
14.66M
Average
15.33M
Median
Jul 2022
Revenue (TTM) Benchmarks
Aurinia Pharmaceuticals Inc | 220.36M |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | 0.411M |
Xenon Pharmaceuticals Inc | -- |
ESSA Pharma Inc | -- |